XELJANZ
11MG TBL PRO 91
| SÚKL code | 0238764 |
|---|---|
| Name of the product | XELJANZ |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | XELJANZ |
| Supplement | 11MG TBL PRO 91 |
| Strenght | 11MG |
| Pharmaceutical form | Prolonged-release tablet |
| Package | 91 |
| Route | Oral use |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | TOFACITINIB CITRATE (TOFACITINIBI CITRAS) |
| ATC group | L04AA29 |
| ATC group name | TOFACITINIB |
Marketing authorisation information
| Registration Number | EU/1/17/1178/013 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Pfizer Europe MA EEIG, Bruxelles |
| MA Holder country | BELGIE |
cz